Status: current, Defined. Date: 31-Jul 2008. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2759672013 | Oral form rivastigmine (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 2771678013 | Oral form rivastigmine | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3487593012 | Product containing rivastigmine in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3496113013 | Product containing rivastigmine in oral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3496114019 | Rivastigmine in oral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3711787014 | Product containing rivastigmine in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3711788016 | Rivastigmine-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rivastigmine-containing product in oral dose form | Plays role | Antidementia therapeutic role | true | Inferred relationship | Some | ||
| Rivastigmine-containing product in oral dose form | Is a | Antidementia agent | true | Inferred relationship | Some | ||
| Rivastigmine-containing product in oral dose form | Is a | Rivastigmine-containing product | true | Inferred relationship | Some | ||
| Rivastigmine-containing product in oral dose form | Has active ingredient | Rivastigmine | true | Inferred relationship | Some | 1 | |
| Rivastigmine-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Rivastigmine-containing product in oral dose form | Is a | Product manufactured as oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Rivastigmine only product in oral dose form | Is a | True | Rivastigmine-containing product in oral dose form | Inferred relationship | Some | |
| Rivastigmine (as rivastigmine tartrate) 2 mg/mL oral solution | Is a | False | Rivastigmine-containing product in oral dose form | Inferred relationship | Some | |
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Is a | False | Rivastigmine-containing product in oral dose form | Inferred relationship | Some | |
| Rivastigmine (as rivastigmine tartrate) 3 mg oral capsule | Is a | False | Rivastigmine-containing product in oral dose form | Inferred relationship | Some | |
| Rivastigmine (as rivastigmine tartrate) 1.5 mg oral capsule | Is a | False | Rivastigmine-containing product in oral dose form | Inferred relationship | Some | |
| Rivastigmine (as rivastigmine tartrate) 6 mg oral capsule | Is a | False | Rivastigmine-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR